Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleImmunology

Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease

Catharina H.M.J. Van Elssen, Mohammad Rashidian, Vladimir Vrbanac, Kai W. Wucherpfennig, Zeina el Habre, Jana Sticht, Christian Freund, Johanne T. Jacobsen, Juanjo Cragnolini, Jessica Ingram, Loes Plaisier, Eric Spierings, Andrew M. Tager and Hidde L. Ploegh
Journal of Nuclear Medicine June 2017, 58 (6) 1003-1008; DOI: https://doi.org/10.2967/jnumed.116.186007
Catharina H.M.J. Van Elssen
1Division of Hematology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mohammad Rashidian
2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vladimir Vrbanac
4Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai W. Wucherpfennig
5Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts
6Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeina el Habre
7Protein Engineering Group, Leibniz Institute for Molecular Pharmacology and Freie Universität Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jana Sticht
7Protein Engineering Group, Leibniz Institute for Molecular Pharmacology and Freie Universität Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christian Freund
7Protein Engineering Group, Leibniz Institute for Molecular Pharmacology and Freie Universität Berlin, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johanne T. Jacobsen
2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
8Center for Immune Regulation, Oslo University Hospital, University of Oslo, Oslo, Norway
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juanjo Cragnolini
2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jessica Ingram
2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loes Plaisier
9Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Spierings
9Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew M. Tager
4Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts
10Center for Immunology and Inflammatory Diseases, Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Charlestown, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hidde L. Ploegh
2Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
3Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Characterization of anti–human class II MHC VHH (VHH4). (A) Schematic representation of sortase reaction to site-specifically labeled VHHs followed by liquid chromatography–mass spectrometry analysis. Sortase recognizes LPXTG motif and replaces G residue with substrate containing a NH2-G3-R moiety, where R represents tag of interest. Liquid chromatography–mass spectrometry analysis on VHH4 and VHH4-Texas Red confirms efficient labeling for VHH4. (B) Sodium dodecyl sulfate polyacrylamide gel electrophoresis characterization of VHH4: lane 1, marker; lane 2, VHH4; lane 3, VHH4-Texas Red (left); and same sodium dodecyl sulfate polyacrylamide gel electrophoresis gel scanned for Texas Red fluorophore (right). (C) Freshly isolated human peripheral blood lymphocytes cells were stained with VHH4-Texas Red and B and T cell lineage-specific antibodies. Representative data of 1 of 3 donors.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Human reconstitution of BLT mice. BLT mice were injected with 10 μg of VHH4-Texas Red via tail vein injection. Two hours after injection, mice were euthanized and organs isolated. (A) Single cell suspensions were prepared. By flow cytometry, cells were gated on human CD45 and analyzed for expression of class II MHC (VHH4) and B and T cell lineage markers; data representative of 5 individual experiments. (B) Percentages of human CD45-positive cells in different organs as analyzed by flow cytometry. (C) Analysis of VHH4 staining in spleen, lymph node, and thymus by 2-photon microscopy on Hu-BLT mice (n = 3) or in spleen of nonreconstituted NOD/SCID mouse, analyzed by 2-photon microscopy (n = 3). BM = bone marrow; LN = lymph node.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    PET/CT imaging of human reconstitution in BLT mice using radiolabeled VHH4. (A) Schematic representation of radiolabeling of VHHs using sortase. VHH4 was first labeled using sortase with a chelator molecule, 1,4,7-triazacyclononane-triacetic acid, and then was radiolabeled using 64Cu. (B) PET/CT images of BLT mouse (left) and NOD/SCID mouse (right) imaged at 2 h after injection of 64Cu-VHH4. For BLT mouse, PET images show increased signal in spleen and bone marrow. Images are representative data of 4 different BLT mice. For NOD/SCID images, accumulation of signal in kidneys is nonspecific. Images are representative of 2 NOD/SCID mice. (C) PET SUVs of BLT and NOD/SCID mice shown in B. PET scale bars represent SUVs; CT scale bars have arbitrary units. Supplemental Videos 1 and 2 provide better 3-dimensional visualization. Images are all window-leveled to same intensity.

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    Imaging of GvHD in hu-BLT mice using VHH4. Mice with and without clinical symptoms of GvHD were injected with Texas Red–labeled or 64Cu-labeled-VHH4. Mice were either euthanized 2 h after injection to collect organs or imaged by PET/CT. (A) Phenotype of BLT mice with GvHD stage 0 or stage 3. (B) PET/CT images of BLT mouse with stage 3 GvHD (n = 2). PET/CT images show intense PET signal in spleen, marrow, and liver. Supplemental Video 3 provides better 3-dimensional visualization. On top right is shown transverse PET/CT image of liver of same mouse for better visualization of signal. PET scale bars represent SUVs; CT scale bars have arbitrary units. Below transverse image is PET SUVs for BLT mice with stage 0 GvHD (n = 2) and stage 3 GvHD (n = 2) imaged with 64Cu-labeled VHH4. (C) Two-photon imaging of the liver of a BLT mouse without clinical sings of GvHD (stage 0) or with stage 3 GvHD. (D and E) Single-cell suspensions of different organs were prepared for mice with GvHD stage 3 (D) or stage 0 (E). By flow cytometry, cells were gated on human CD45 and analyzed for expression of human class II MHC and T cell lineage markers. BM = bone marrow; LN = lymph node.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
    • 186007 Supplemental Video 1
    • 186007 Supplemental Video 2
    • 186007 Supplemental Video 3
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (6)
Journal of Nuclear Medicine
Vol. 58, Issue 6
June 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease
Catharina H.M.J. Van Elssen, Mohammad Rashidian, Vladimir Vrbanac, Kai W. Wucherpfennig, Zeina el Habre, Jana Sticht, Christian Freund, Johanne T. Jacobsen, Juanjo Cragnolini, Jessica Ingram, Loes Plaisier, Eric Spierings, Andrew M. Tager, Hidde L. Ploegh
Journal of Nuclear Medicine Jun 2017, 58 (6) 1003-1008; DOI: 10.2967/jnumed.116.186007

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease
Catharina H.M.J. Van Elssen, Mohammad Rashidian, Vladimir Vrbanac, Kai W. Wucherpfennig, Zeina el Habre, Jana Sticht, Christian Freund, Johanne T. Jacobsen, Juanjo Cragnolini, Jessica Ingram, Loes Plaisier, Eric Spierings, Andrew M. Tager, Hidde L. Ploegh
Journal of Nuclear Medicine Jun 2017, 58 (6) 1003-1008; DOI: 10.2967/jnumed.116.186007
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Molecular Imaging of Acute Graft-Versus-Host Disease
  • Single-Domain Antibody Theranostics on the Horizon
  • A class II MHC-targeted vaccine elicits immunity against SARS-CoV-2 and its variants
  • Molecular Imaging of Chimeric Antigen Receptor T Cells by ICOS-ImmunoPET
  • Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease
  • The Immunoimaging Toolbox
  • Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells
  • Google Scholar

More in this TOC Section

  • Small-Animal PET/CT Imaging of Local and Systemic Immune Response Using 64Cu-αCD11b
Show more Immunology

Similar Articles

Keywords

  • GVHD
  • Single domain antibodies
  • immunoPET
  • humanized Mice
SNMMI

© 2025 SNMMI

Powered by HighWire